Advertisement
Screener

ABSCI CORP (ABSI) Long-Term Debt, Maturity, Year Two

2.8 / 5 stars · 68/120 Roast Me

ABSCI CORP Long-Term Debt, Maturity, Year Two

ABSCI CORP (ABSI) had Long-Term Debt, Maturity, Year Two of $1.29 million as of 2024-12-31, per its 10-K filed 2025-03-18.

Financial Statements › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity

us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo · last filed 2025-03-18

  • 2024-12-31: Long-Term Debt, Maturity, Year Two $1.29M.
  • 2023-12-31: Long-Term Debt, Maturity, Year Two $3.40M.
  • 2022-12-31: Long-Term Debt, Maturity, Year Two $3.83M.
  • 2022-09-30: Long-Term Debt, Maturity, Year Two $3.02M.
Period endLong-Term Debt, Maturity, Year Two
2024-12-31$1.29M
10-K · filed 2025-03-18
2023-12-31$3.40M
10-K · filed 2024-03-21
2022-12-31$3.83M
10-K · filed 2023-03-30
2022-09-30$3.02M
10-Q · filed 2022-11-09
2022-06-30$3.02M
10-Q · filed 2022-08-11
2021-12-31$1.15M
10-K · filed 2022-03-22

Similar stocks

Stock NameCountryMarket CapPE Ratio
OmniAb, Inc. (OABI)United States$0.698B-8.05
NRC HEALTH (NRC)United States$0.450B42.50
MAXCYTE, INC. (MXCT)United States$0.124B-3.68
bioAffinity Technologies, Inc. (BIAF)United States$0.063B
OneMedNet Corp (ONMD)$0.042B
iSpecimen Inc. (ISPC)United States$0.003B
FOXO TECHNOLOGIES INC. (FOXO)United States$0.000B-277.71
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)United States$14.060B-43.97
Medpace Holdings, Inc. (MEDP)United States$17.316B30.09
INCYTE CORP (INCY)United States$24.855B13.14